nodding to the recently unveiled Project Stargate initiative. “In essence, Palantir is in the sweet spot to benefit from a tidal wave of federal spending on AI.” Elsewhere, William Blair rates ...

Fintel reports that on April 8, 2025, William Blair initiated coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a Outperform recommendation. As of April 2, 2025, the average one-year price ...

NYSE:SVV opened at $7.59 on Friday. Savers Value Village has a 12 month low of $6.48 and a 12 month high of $18.93. The company has a current ratio of 1.04, a quick ratio of 0.86 and a debt-to ...

Fintel reports that on April 4, 2025, William Blair initiated coverage of Savers Value Village (NYSE:SVV) with a Outperform recommendation. As of April 2, 2025, the average one-year price target ...

In a report released today, Andy Hsieh from William Blair maintained a Buy rating on Skye Bioscience (SKYE – Research Report). The company’s shares opened today at $1.48. Discover ...

On Tuesday, William Blair initiated coverage on Immunic Inc. (NASDAQ:IMUX) with an Outperform rating, highlighting the potential of its relapse-remitting multiple sclerosis (RMS) therapy ...

In a report released today, Matt Larew from William Blair maintained a Buy rating on 908 Devices (MASS – Research Report). The company’s shares opened today at $4.43. Discover outperforming ...

Investing.com -- William Blair remains optimistic on Tesla (NASDAQ:TSLA) despite recent setbacks, forecasting that shares will bottom and momentum will rebound as expectations reset. The firm ...

Below, we'll analyze his recent form to help you make your best bets on Blair before he takes to the course in Punta Cana, DOM. ESPN+ is the new home of PGA TOUR LIVE. Sign up now to access 4,300 ...

William Blair Large Cap Growth Fund earns an Average Process Pillar rating. The leading factor in the rating is the stability of the management team. Specifically, the fund has not seen a manager ...